A Modified Single Mini-Incision Complete Urinary Tract Exenteration for Urothelial Carcinoma in Dialysis Patients

Table 1

Patient demographics and perioperative parameters.

Pt	Age (y)	Duration of HD (yr)	BMI (kg/m^2)	ECOG	Clinically surgical indication	Hydronephrosis	Pathologic tumor location (T stage)^a	Comorbidity
1	63	9	21.4	0	UB & LU	Left	UB(is) & LU(1); LK ccRCC(1a)	HTN
2	50	14	21.7	0	UB & RU	Right	UB(1) & RU(3)	HTN
3	61	8	25.9	1	UB & RU**	Right	UB(a) & RU(a)	HTN, HCC, cirrhosis,; hepatitis B & C,; SHPT
4	75	6	31.5	0	UB & LU; LK	Left	UB(a) & LU(a); LK(a)	None
5	63	17	17.1	1	UB & LK	Bilateral	UB(1) & LK(3); LU(a)	HTN, hepatitis C,; pulmonary TB
6	52	4	31.8	0	UB & RK	No	UB(1) & RK(1)	HTN, DM
7	67	1	20.4	1	BK & RU	Right	BK(a) & RU(1)	HTN, CHF
8	80	6	17.0	1	UB & LU**	Bilateral	UB(2a) & LU(a); RK(a) & RU(a)	HTN, DM,; moderate MR
9	58	9	21.3	1	UB & RU	No	UB(is) & RU(1); LU(is)	SHPT
10	70	2	22.6	1	UB & RU**	Right	UB(1) & RU(1)	HTN, old CVA,; parkinsonism
11	57	8	22.2	1	UB**	Left	UB(2a); LU(is) & RU(3)	SHPT
12	57	13	17.3	1	UB**	Left	UB(1)	Pulmonary TB
13	53	10	21.5	0	UB	No	UB(1); LU(a)	HTN, hepatitis B
14	48	11*	21.2	1	UB	Left	UB(1)	HTN, hepatitis C,; SHPT, peritonitis***

HD, hemodialysis; BMI, body mass index; ECOG, eastern cooperative oncology group performance status; UB, urinary bladder; LU, left ureter; RU, right ureter; LK, left kidney; RK, right kidney; BK, bilateral kidney; ccRCC, clear cell renal cell carcinoma; HTN, hypertension; HCC, hepatocellular carcinoma; SHPT, secondary hyperparathyroidism; TB, tuberculosis; DM, diabetes mellitus; CHF, congestive heart failure; CVA, cardiovascular accident.
^aAll patients had high-grade urothelial carcinoma.
*Peritoneal dialysis.
**Surgical indication was recurrent urothelial cancer.
***Continuous ambulatory peritoneal dialysis (CAPD) related sclerosing peritonitis.